Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Conversation
The Conversation
Quing Zhu, Professor of Engineering, Washington University in St. Louis

About 80% of breast cancer biopsies turn out benign – new imaging tool promises clearer diagnoses and fewer biopsies

Ultrasound is standard for breast cancer screening, but it has its limitations. Anchiy/E+ via Getty Images

Ultrasound is widely used in breast cancer diagnosis. While it can effectively show that a lump is filled with fluid – indicating it is unlikely to be cancer – it cannot reliably determine whether a solid mass is benign or cancerous. This often leads doctors to order breast biopsies to confirm the presence of cancer.

However, most breast biopsies do not detect cancer. In the U.S., more than 1 million breast biopsies are performed each year, and about 80% of them are benign. Unnecessary biopsies are linked to potential harms, including increased anxiety, complications from the procedure and medical costs. Despite advances in breast imaging, breast biopsy remains the only definitive method to determine whether a suspicious lump is cancerous.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.